US Bancorp
RGEN icon

US Bancorp’s Repligen RGEN Stock Holding History

US Bancorp’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
18,869
+4,665
+33% +$652K ﹤0.01% 839
2025
Q4 		$2.33M Buy
14,204
+4,101
+41% +$642K ﹤0.01% 827
2025
Q3 		$1.35M Buy
10,103
+938
+10% +$114K ﹤0.01% 1030
2025
Q2 		$1.14M Sell
9,165
-1,463
-14% -$186K ﹤0.01% 1070
2025
Q1 		$1.35M Buy
10,628
+406
+4% +$62.5K ﹤0.01% 995
2024
Q4 		$1.47M Buy
10,222
+190
+2% +$27.2K ﹤0.01% 981
2024
Q3 		$1.49M Sell
10,032
-261
-3% -$37.4K ﹤0.01% 961
2024
Q2 		$1.3M Buy
10,293
+963
+10% +$151K ﹤0.01% 997
2024
Q1 		$1.72M Sell
9,330
-2,476
-21% -$472K ﹤0.01% 899
2023
Q4 		$2.12M Buy
11,806
+2,114
+22% +$329K ﹤0.01% 806
2023
Q3 		$1.54M Buy
9,692
+2,322
+32% +$380K ﹤0.01% 891
2023
Q2 		$1.04M Sell
7,370
-1,973
-21% -$316K ﹤0.01% 1047
2023
Q1 		$1.57M Sell
9,343
-7,196
-44% -$1.28M ﹤0.01% 895
2022
Q4 		$2.8M Sell
16,539
-2,007
-11% -$364K 0.01% 696
2022
Q3 		$3.47M Sell
18,546
-4,344
-19% -$916K 0.01% 598
2022
Q2 		$3.72M Buy
22,890
+5,085
+29% +$804K 0.01% 602
2022
Q1 		$3.35M Buy
17,805
+1,342
+8% +$255K 0.01% 683
2021
Q4 		$4.36M Buy
16,463
+608
+4% +$164K 0.01% 632
2021
Q3 		$4.58M Buy
15,855
+8,588
+118% +$2.2M 0.01% 587
2021
Q2 		$1.45M Buy
7,267
+908
+14% +$176K ﹤0.01% 1014
2021
Q1 		$1.24M Buy
6,359
+527
+9% +$108K ﹤0.01% 1042
2020
Q4 		$1.12M Buy
5,832
+2,340
+67% +$426K ﹤0.01% 1059
2020
Q3 		$515K Sell
3,492
-610
-15% -$87.2K ﹤0.01% 1318
2020
Q2 		$508K Sell
4,102
-908
-18% -$107K ﹤0.01% 1279
2020
Q1 		$483K Buy
5,010
+316
+7% +$30.5K ﹤0.01% 1216
2019
Q4 		$434K Buy
4,694
+803
+21% +$67.5K ﹤0.01% 1442
2019
Q3 		$298K Buy
3,891
+369
+10% +$32.3K ﹤0.01% 1610
2019
Q2 		$302K Buy
3,522
+435
+14% +$29.7K ﹤0.01% 1638
2019
Q1 		$182K Hold
3,087
– – ﹤0.01% 1861
2018
Q4 		$162K Sell
3,087
-495
-14% -$29K ﹤0.01% 1871
2018
Q3 		$199K Hold
3,582
– – ﹤0.01% 1873
2018
Q2 		$169K Hold
3,582
– – ﹤0.01% 1954
2018
Q1 		$129K Sell
3,582
-43
-1% -$1.51K ﹤0.01% 2104
2017
Q4 		$132K Buy
3,625
+1
+0% +$36 ﹤0.01% 2117
2017
Q3 		$139K Sell
3,624
-1,005
-22% -$42.1K ﹤0.01% 2053
2017
Q2 		$191K Buy
4,629
+54
+1% +$2.05K ﹤0.01% 1864
2017
Q1 		$161K Sell
4,575
-130
-3% -$4.12K ﹤0.01% 1927
2016
Q4 		$146K Buy
4,705
+3,479
+284% +$108K ﹤0.01% 1938
2016
Q3 		$37K Hold
1,226
– – ﹤0.01% 2596
2016
Q2 		$34K Buy
1,226
+93
+8% +$2.38K ﹤0.01% 2591
2016
Q1 		$30K Sell
1,133
-74
-6% -$1.81K ﹤0.01% 2612
2015
Q4 		$35K Buy
1,207
+23
+2% +$663 ﹤0.01% 2607
2015
Q3 		$33K Buy
1,184
+445
+60% +$16.1K ﹤0.01% 2660
2015
Q2 		$30K Sell
739
-323
-30% -$11.8K ﹤0.01% 2778
2015
Q1 		$32K Sell
1,062
-1,021
-49% -$26.5K ﹤0.01% 2746
2014
Q4 		$41K Buy
2,083
+481
+30% +$10.8K ﹤0.01% 2625
2014
Q3 		$32K Buy
1,602
+1,302
+434% +$27.4K ﹤0.01% 2688
2014
Q2 		$7K Hold
300
– – ﹤0.01% 3149
2014
Q1 		$4K Hold
300
– – ﹤0.01% 3257
2013
Q4 		$4K Hold
300
– – ﹤0.01% 3187
2013
Q3 		$3K Sell
300
-600
-67% -$5.97K ﹤0.01% 3149
2013
Q2 		$7K Buy
+900
New +$7.56K ﹤0.01% 2929

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

US Bancorp's RGEN Position: Q1 2026 in Review

US Bancorp increased its Repligen (RGEN) stake by 33% in Q1 2026, buying an estimated $652K and bringing the position to 18,869 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #839.

US Bancorp first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.58M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • US Bancorp held 18,869 shares of Repligen worth $2.22M as of Q1 2026.
  • US Bancorp bought 4,665 Repligen shares in Q1 2026, an estimated $652K.
  • Repligen made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #839 holding.
  • US Bancorp first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Repligen position peaked at $4.58M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.